
PIRS
Healthcare · Biotechnology · $21.1M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2023
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2024 | After the close | — | -2.19 | — |
| Aug 14, 2024 | After the close | — | -2.76 | — |
| May 15, 2024 | After the close | -0.12 | -3.95 | -3195.6% |
| Mar 29, 2024 | After the close | -0.12 | -3.70 | -2983.3% |
| Nov 15, 2023 | Before the open | -0.11 | 0.04 | +136.4% |
| Aug 10, 2023 | After the close | -0.16 | 0.05 | +131.3% |
| May 10, 2023 | Before the open | -0.14 | -0.18 | -28.6% |
| Mar 29, 2023 | Before the open | -0.23 | -0.11 | +52.2% |
| Nov 2, 2022 | Before the open | -0.16 | -0.13 | +18.8% |
| Aug 4, 2022 | Before the open | -0.11 | -0.14 | -27.3% |
| May 11, 2022 | Before the open | -0.11 | -0.07 | +36.4% |
| Mar 1, 2022 | Before the open | -0.30 | -0.13 | +56.7% |
| Nov 2, 2021 | Before the open | -0.24 | -0.24 |
Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches…
| 0.0% |
| Aug 4, 2021 | Before the open | -0.26 | -0.25 | +3.8% |
| May 17, 2021 | Before the open | -0.17 | -0.07 | +58.8% |
| Mar 30, 2021 | Before the open | -0.24 | -0.26 | -8.3% |
| Nov 4, 2020 | Before the open | -0.13 | -0.26 | -100.0% |
| Aug 10, 2020 | Before the open | -0.17 | -0.09 | +47.1% |
| May 11, 2020 | Before the open | -0.17 | -0.07 | +58.8% |
| Mar 12, 2020 | Before the open | -0.28 | -0.06 | +78.6% |
| Nov 11, 2019 | Before the open | -0.23 | -0.05 | +78.3% |
| Aug 9, 2019 | After the close | -0.20 | -0.24 | -20.0% |
| May 10, 2019 | After the close | -0.20 | -0.20 | 0.0% |
| Mar 18, 2019 | After the close | -0.15 | -0.21 | -40.0% |
| Nov 7, 2018 | Before the open | -0.12 | -0.11 | +8.3% |
| Aug 9, 2018 | Before the open | -0.01 | -0.00 | +62.0% |
| May 10, 2018 | Before the open | -0.03 | -0.17 | -466.7% |
| Mar 9, 2018 | Before the open | -0.07 | 0.18 | +357.1% |